Chronic (Cold) Contact Urticaria Treated Successfully with Anti-IgE (Omalizumab)

References (8)

1. Schwartz LB, Delgado L, Craig T, Bonini S, Carlsen KH, Casale TB, et al. Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: A PRACTALL consensus report (what the general practitioner should know about sports and allergy). Allergy 2008:63:953-61
2. Buss YL, Sticherling M. Cold urticaria; disease course and outcome – an investigation of 85 patients before and after therapy. Br J Dermatol 2005;153:440-1
3. Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol 2006;117:1415-8
4. Ombrello MJ, Remmers EF, Sun G, Freeman AF, Datta S, Torabi-Parizi P, et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med 2012;366:330-8
5. Kessel A, Yaacoby-Bianu K, Vadasz Z, Peri R, Halazs K, Toubi E. Elevated serum B-cell activating factor in patients with chronic urticaria. Hum Immunol 2012;73(6):620-2
6. Metz M, Schütz A, Weller K, Gorczyza M, Zimmer S, Staubach P. Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial. J Allergy Clin Immunol 2017;140(3):864-7.e5
7. Kulthanan K, Hunnangkul S, Tuchinda P, Chularojanamontri L, Weerasubpong P, Subchookul C. Treatments of cold urticaria: A systematic review. J Allergy Clin Immunol 2019;143(4):1311-31
8. Damiani G, Diani M, Conic RRZ, Colli L, Ferrucci S, Martina E. Omalizumab in chronic urticaria: An Italian survey. Int Arch Allergy Immunol 2019;178(1):45-9.